You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. An Integrated System for Borehole Magnetometric Resistivity and Electrical Resistivity Tomography Data Acquistion, Processing and Visualization

    SBC: Multi Phase Technologies LLC            Topic: 13a

    The U.S. DOE Office of Environmental Management (EM) was created in 1989 to manage the cleanup of large areas of environmentally contaminated sites. Since the closure of many of these sites, U.S. taxpayers have spent about $220 billion at 74 cleanup sites. However, these sites were the smallest and most manageable sites to clean. There are still over 40 sites that are deemed as eno ...

    SBIR Phase I 2013 Department of Energy
  2. High-Energy, High-Power Light Weight Lithium Ion Batteries For Electric Drive Vehicle

    SBC: Yardney Technical Products, Inc.            Topic: 06a

    Electric vehicles, hybrid electric vehicles, and plugin hybrid electric vehicles (EVs, HEVs, and PHEVs) are emerging technologies that can significantly reduce petroleum usage in the transportation sector. Widespread adoption of electricdrive vehicles will lower automobile operation costs and can significantly decrease emissions of greenhouse gases. However, for these technologies to be successful ...

    SBIR Phase I 2013 Department of Energy
  3. Immunoassay for diagnosis of invasive fungal disease

    SBC: Immuno-mycologics, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Early diagnosis of infectious disease is critical to patient outcome. An important early question is - is it a fungus, a bacterium or a virus? A rapid answer to this question would allow preemptive treatment that cansave lives. The goal of this project is a rapid and inexpensive immunoassay that will use serum as a sample to broadly identify the presence of ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  4. Biomarker discovery for immunodiagnosis of invasive candidiasis

    SBC: DXDISCOVERY INC            Topic: NIAID

    DESCRIPTION (provided by applicant): Invasive candidiasis (IC) is one of the most serious threats to patients in a critical setting. With as many as 60,000 cases per year in the U.S., the total cost associated with IC in the U.S. may be as high as 2-4 billion/year. One of the most critical factors influencing patient outcome is early diagnosis. The goal of this project is a rapi and inexpensive i ...

    STTR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  5. Selection-driven plant metabolites for treatment of CNS diseases

    SBC: COARE BIOTECHNOLOGY, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Pancreatic ductal adenocarcinoma (PDAC) is a solid tumor and is the fourth leading cause of cancer-related death in the U.S. The 5-year survival rate of its victims is lt5%. There is increasing evidence that most solidtumors have a subpopulation of tumor-initiating cells termed cancer stem cells (CSCs). The inability to eradicate these CSCs is postulated to b ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  6. Expanding Precision Particle Fabrication Technology for the Widespread Control of

    SBC: TRANSTIMULATION RESEARCH INC            Topic: NIDDK

    DESCRIPTION (provided by applicant): Diabetes affects more than 8% of Americans and costs over 174 billion in 2007 in USA. Recently bariatric surgery, such as Roux-en-Y gastric bypass, has been proposed for treating diabetic patients with obesity due to its hypoglycemic effect on postprandial blood glucose and significant weight loss. In this proposal, we propose a novel method of automated inte ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Developing A Novel Therapy for Diabetic Retinopathy

    SBC: Charlesson, LLC            Topic: NEI

    DESCRIPTION (provided by applicant): Diabetic retinopathy (DR) is a common complication of diabetes and a leading cause of vision loss in the United States. Unfortunately, there is no FDA-approved pharmacotherapy for DR. Current treatments in clinical practice and trails, such as laser photocoagulation, corticosteroids and anti-vascular endothelial growth factor (VEGF) agents, are effective in som ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. An Automated Platform for High-throughput Network Electrophysiology

    SBC: CALISTA THERAPEUTICS INC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Calista Therapeutics has discovered a first-in-class, proprietary PDZ1-2 lead drug, AT010, that is being optimized and developed as an inhaled daily therapy for cystic fibrosis (CF). CF is a deadly inherited genetic disorder that disrupts chloride channel function, resulting in the buildup of sticky mucus in patient's lungs and other organs.CF patients hav ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. Developing an Improved Electrocompetent E. coli Host

    SBC: Pro-Change Behavior Systems, Inc.            Topic: NCATS

    DESCRIPTION (provided by applicant): Chronic musculoskeletal pain creates a significant public health burden. Veterans are disproportionately affected by chronic musculoskeletal pain, and in particular, chronic low back pain (CLBP). The frequency and extent of co-occurrence of pain and PTSD, pain and Traumatic Brain Injury (TBI), and all three conditions (Post-deployment Multi-symptom Disorder (PM ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  10. Label-free platform for applications in drug discovery

    SBC: SENSIQ TECHNOLOGIES, INC.            Topic: NCATS

    DESCRIPTION: Incremental improvements in label free screening technologies over the past decade have not produced the capability necessary to support the changing needs of drug discovery programs. Persistent artifacts related to non-specific binding, promiscuous binding, precipitation, complex binding, tubing retention, aggregation, and sub-optimally designed platforms continue to hinder progress ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government